CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial
DOI 10.1055/s-0040-1708133
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Ahmadzadehfar, K Rahbar, RP Baum, C Gerke, C Kratochwil, H Ilhan, M Sathekge, L Kabasakal, F. O Garcia-Perez, K Kairemo, M Maharaj, D Paez, I Virgolini
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial
Zitieren
Zitierempfehlung
H Ahmadzadehfar, K Rahbar, RP Baum, C Gerke, C Kratochwil, H Ilhan, M Sathekge, L Kabasakal, F. O Garcia-Perez, K Kairemo, M Maharaj, D Paez, I Virgolini (2020) The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708133
Mit CareLit weiterarbeiten